Related Experiment Video
Updated: Jul 19, 2026
11:19
Guidelines for Elective Pediatric Fiberoptic Intubation
Published on: January 17, 2011
Propofol in paediatric anaesthesia.
Johan Francois Coetzee1, Mariatha Coetzer
1Department of Anesthesiology and Critical Care, University of Stellenbosch, Tygerberg, South Africa. jfc@sun.ac.za
Current Opinion in Anaesthesiology
|October 6, 2006
Summary
Propofol is increasingly used for pediatric sedation by non-anesthesiologists, but risks exist. Combining propofol with opioids and educating practitioners on its use can improve safety and efficacy.
Area of Science:
- Anesthesiology
- Pediatric Sedation
- Pharmacology
Background:
- Propofol is increasingly utilized for pediatric sedation by various practitioners.
- Concerns exist regarding its administration, particularly for painful procedures, leading to high doses and potential adverse events.
Purpose of the Study:
- To review trends in propofol administration for pediatric anesthesia and sedation.
- To highlight the importance of proper training and drug combinations for safe propofol use.
Main Methods:
- Literature review of propofol administration trends in pediatric patients.
- Analysis of reported adverse events and best practices.
Main Results:
- Non-anesthesiologists are increasingly using propofol for pediatric sedation.
- Combined therapy with opioids and low-dose propofol infusion is effective and safe, even in patients with intracardiac shunts.
- Propofol infusion syndrome remains a risk in prolonged intensive care unit sedation, possibly linked to mitochondrial dysfunction.
Conclusions:
- Educating non-anesthesiologists on propofol pharmacokinetics and pharmacodynamics is crucial.
- Caution is advised for prolonged sedation in ICUs, with dose limits and vigilance for propofol infusion syndrome.
- When used correctly, propofol is a valuable agent for procedural sedation outside the operating room.
Related Concept Videos
01:24Parenteral Anesthetics: Overview
Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
01:20Inhalational Anesthetics: Overview
Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
01:24General Anesthesia: Overview
Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
01:17Pharmacokinetics in Pediatric Patients: Drug Distribution
Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...
01:24Pharmacokinetics in Pediatric Patients: Drug Metabolism
In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses a challenge in...
01:23Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...